Axsome Therapeutics (AXSM) Stock Forecast & Price Prediction

Estimation of the future price movement of Axsome Therapeutics stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

Price target


Current $82.42

Concensus $81.00


Low $25.00

Median $82.50

High $150.00

Based on analysts projections #AXSM is expected to experience a price decline over the next year.

The current average AXSM price target, as estimated by these analysts, is $81.00.

The predictions for the future AXSM stock price range from a low of $25.00 to a high of $150.00, highlighting the variability of market expectations for AXSM.

It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.

AXSM stock forecasts by analyst

Analyst / firm Date Rating Price target Price when posted
Piper Sandler January 5, 2023 Sell 75.00 73.34
Robert Hazlett
BTIG
December 23, 2022 Buy 98.00 75.13
Morgan Stanley November 29, 2022 Buy 86.00 74.95
Leerink Partners November 29, 2022 Buy 85.00 74.74
Guggenheim November 11, 2022 Sell 80.00 55.49
Joon Lee
Truist Financial
August 19, 2022 Buy 150.00 59.03
Mizuho Securities May 3, 2022 Sell 49.00 34.04
Morgan Stanley April 27, 2022 Sell 27.00 30.59
Joon Lee
Truist Financial
March 1, 2022 Buy 90.00 30.98
Ashwani Verma
Bank of America Securities
August 10, 2021 Sell 25.00 23.78

Axsome Therapeutics (AXSM) Fundamentals Checker

Financial metrics are used to evaluate financial stability which helps analysts determine if Axsome Therapeutics is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.

Neutral

Financial Scores

Updated on: 03/03/2024

Altman Z-Score: 3.8

Piotroski Score: 3.0

ESG Score

Updated on: 03/03/2024

Environmental: 56.9

Social: 61.6

Governance: 59.6

Financial Health

Updated on: 03/03/2024

DCF: Buy

ROE: Strong Sell

ROA: Sell

Debt to equity ratio: Strong Buy

Price to earnings ratio: Strong Sell

Price to book ratio: Strong Buy

AXSM Discounted Cash Flow

Updated on: 03/03/2024

$84.761
Discounted Cash Flow Value


$82.420
Current Price

AXSM Revenues by Segment

Updated on: 03/03/2024

Product
$2,024,600.00
License
$657,350.00
Royalty
$24,050.00

Revenue from Contract with Customer, Excluding Assessed Tax

AXSM Revenues by Region

Updated on: 03/03/2024

Non-US
$657,350.00
UNITED STATES
$1,972,240.00

AXSM Notes Due

Updated on: 03/03/2024

CIKExchangeTitle

There are no data to display

Axsome Therapeutics (AXSM) Social Sentiments

Monitoring bullish and bearish sentiments towards Axsome Therapeutics on Twitter and Stocktwits could help to forecast an upward or downward trend in Axsome Therapeutics stock price.

Axsome Therapeutics: A Bullish Stock Forecast in the Biotechnology Sector

Axsome Therapeutics: A Bullish Stock Forecast in the Biotechnology Sector Axsome Therapeutics (AXSM) is a clinical-stage biopharmaceutical company that focuses on developing innovative therapies for neurology and other central nervous system disorders. The company's lead product candidate, AXS-05, is designed to treat major depressive disorder (MDD) and other indications such as treatment-resistant depression (TRD), Alzheimer's disease agitation, and smoking cessation.... Read more

Biotech Breakthroughs: Axsome Therapeutics Emerges as a Promising Stock Prediction in the CNS Disorder Market

Biotechnology is a sector that involves the application of scientific techniques to living organisms, thereby creating products and processes that benefit human lives. This industry has grown exponentially in recent times, with numerous biotech companies emerging as major players in the stock market. Axsome Therapeutics Inc. (AXSM) is one such biotech firm making waves on the stock market today. Axsome... Read more